SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ISHITA DRUGS & INDUSTRIES

BSE: 524400 19 Aug 2025
Healthcare
₹ 75.75
Ishita Drugs & Industries Ltd. specializes in Pharmaceuticals within the Healthcare sector.

ISHITA DRUGS & INDUSTRIES - Share Price & Details

Market Cap
₹22.6
High /Low
99.6 / 62.4
Stock P/E
22.2
Book Value
₹36.1
Dividend Yield
0.0
ROCE
9.91
ROE
₹8.4
Face Value
10.0
PEG Ratio
7.82
EVEBITDA
₹14.1
Debt
3.90
CMP / FCF
-14.3
Debt to equity
₹0.36
NP Ann
0.87
High price all time
105.0
Piotroski score
₹3.0
Graham Number
52.6
No. Eq. Shares
0.3
Net CF
₹0.02
Net profit
1.02
Price to book value
2.1
Interest Coverage
₹17.8
Low price all time
4.91
Industry PE
33.8
Reserves
₹7.80
Free Cash Flow
₹-3.82

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
ISHITA DRUGS & INDUSTRIES LTD.NANANANA22.622.2
PHAARMASIA LTD.56.14-5.2554.30-0.7721.9
CHEMO PHARMA LABORATORIES LTD.-1.64-3.40NA-2.2621.362.6

Peer Comparison Chart


About ISHITA DRUGS & INDUSTRIES

Ishita Drugs & Industries Ltd., with Security Code 524400, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Ishita Drugs & Industries Reports Strong Short-Term Gains Amid Long-Term Growth Concerns

(15 Aug 2025)
Ishita Drugs & Industries has recently adjusted its evaluation, highlighting significant improvements in financial performance for the quarter ending June...
Read more →

Ishita Drugs & Industries Reports Strong Financial Growth in June 2025 Results

(13 Aug 2025)
Ishita Drugs & Industries has announced its financial results for the quarter ending June 2025, highlighting significant growth.
Read more →

Ishita Drugs & Industries standalone net profit rises 100.00% in the June 2025 quarter

(13 Aug 2025)
Net profit of Ishita Drugs & Industries rose 100.00% to Rs 0.30 crore in the quarter ended June 2025 as against Rs 0.15 crore during the previous quarter...
Read more →

Olympia Industries standalone net profit rises 37.93% in the June 2025 quarter

(13 Aug 2025)
Net profit of Olympia Industries rose 37.93% to Rs 0.40 crore in the quarter ended June 2025 as against Rs 0.29 crore during the previous quarter ended June...
Read more →

Oxford Industries standalone net profit rises 2700.00% in the June 2025 quarter

(13 Aug 2025)
Net profit of Oxford Industries rose 2700.00% to Rs 0.28 crore in the quarter ended June 2025 as against Rs 0.01 crore during the previous quarter ended...
Read more →

Mardia Samyoung Capillary Tubes Company reports standalone net loss of Rs 0.23 crore in the June 2025 quarter

(13 Aug 2025)
Net Loss of Mardia Samyoung Capillary Tubes Company reported to Rs 0.23 crore in the quarter ended June 2025 as against net loss of Rs 0.18 crore during the...
Read more →

Company Updates